Amgen Q2 Earnings Preview: Will the Beat Streak Continue?
Amgen heads into Q2 earnings with a history of beats as investors watch key drug sales trends and seek updates on its MariTide obesity candidate.
Why it matters
Attributed market update with source link for portfolio context.